Variables | N | % |
---|---|---|
Patients | 508 | Â |
Male | 294 | 57.9 |
Female | 214 | 42.1 |
Median age, years (range) | 36 (15–62) |  |
15-39 | 313 | 61.6 |
≥40 | 195 | 38.4 |
Disease | Â | Â |
AML | 231 | 45.5 |
CR | 188 | 37.0 |
PR | 2 | 0.4 |
NR | 41 | 8.1 |
ALL | 86 | 16.9 |
CR | 80 | 15.7 |
NR | 6 | 1.2 |
CML | 156 | 30.7 |
CP | 127 | 25.0 |
AP | 10 | 2.0 |
BC | 19 | 3.7 |
MDS-RAEB | 35 | 6.9 |
Disease stage | Â | Â |
Non-advanced | 441 | 86.8 |
Advanced | 67 | 13.2 |
Donor-recipient gender | Â | Â |
Female–male | 140 | 27.6 |
other | 368 | 72.4 |
Stem cell sources | Â | Â |
PB + BM | 250 | 49.2 |
PB | 258 | 50.8 |
ABO blood group status | Â | Â |
Match | 305 | 60.0 |
Mismatch | 203 | 40.0 |
MMF Dose | Â | Â |
0.5Â g/d | 151 | 29.7 |
1.0Â g/d | 357 | 70.3 |
Conditioning regimens | Â | Â |
BuCy | 347 | 68.3 |
TBICy | 26 | 5.1 |
BuFlu | 135 | 26.6 |